Sign up
Log in
BUZZ-U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Share
Listen to the news
BUZZ-U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio

Eikon search string for individual stock moves: STXBZ

The Day Ahead : https://refini.tv/3LI4BU7

The Morning News Call : https://refini.tv/3dKUyB8

U.S. stock index futures edged higher on Tuesday, building on strong gains in recent weeks as investors continued to bet on a policy pivot by the Federal Reserve year. .N


At 7:02 ET, Dow e-minis 1YMc1 were up 0.06% at 37,699. S&P 500 e-minis ESc1 were up 0.08% at 4,797, while Nasdaq 100 e-minis NQc1 were up 0.08% at 16,953.25.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Natuzzi Spa , up 8.4%
** Enel Chile Sa , up 6.2%
** Eg Acquistn Ord , up 5.6%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Gaotu Techdu Drc , down 7.2%
** Adc Therptcs Ord , down 6.4%
** Elemnt Soltn Inc , down 5.4%

The top three Nasdaq percentage gainers premarket .PRPG.O:
** LogicMark Inc , up 102.4%
** Infobird Co Ltd , up 84.5%
** Panbela Therapeutics Inc , up 61.4%

The top three Nasdaq percentage losers premarket .PRPL.O:
** Prospector Capital Corp , down 59.6%
** Accretion Acquisition Corp , down 54.5%
** Motus Gi Holdings Inc , down 46%


** Chewy Inc CHWY.N: up 2.2% premarket
BUZZ - Rises as Jefferies starts with 'buy'


** Bluebird bio Inc BLUE.O: down 14.1% premarket
BUZZ - Down after announcing public offering


** Amgen Inc AMGN.O: up 1.4% premarket
BUZZ - Rises after BMO upgrades to 'outperform'



(Compiled by Rajarshi Roy and Sneha S K)

((Sneha.sk@thomsonreuters.com))

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.